STOCK TITAN

Arteris (AIP) Financials

AIP NASDAQ
Trailing 12 months to September 30, 2026
Revenue $93.0M +41.0% YoY
Net Income -$41.7M n/m YoY
EPS (Diluted) -$0.89 n/m YoY
Free Cash Flow $2.2M n/m YoY
Market Cap $935.5M as of Nov 18, 2026
Price / Sales 10.1x on $93.0M revenue, trailing 12 months to September 30, 2026
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to September 30, 2026
Price / Book 14.2x on $65.9M equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 18, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Nov 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AIP SEC filings page.

Arteris, Inc. (AIP) reported $93.0M in revenue over the twelve months to Sep 30, 2026, up 41.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AIP FY2025

Revenue growth now produces positive operating cash, but the balance sheet remains liability-funded while reported losses remain substantial.

Cash conversion changed sharply: after negative operating cash flow in FY2024, FY2025 produced $6.7M despite a net loss of $34.7M. Free cash flow reached $5.3M versus operating cash flow of $6.7M, indicating that reported cash generation exceeded the business's reinvestment needs in the latest year even though accounting earnings remained negative.

Revenue grew 22.3% in FY2025 while gross margin improved 0.6 percentage points, indicating expansion without sacrificing gross economics. Yet operating margin was -46.9%, with R&D consuming 70.7% of revenue; operating investment still absorbs the gross profit.

Liabilities grew 20.8% while assets grew 8.4% in FY2025, showing a more liability-funded balance sheet. Liabilities reached 112.7% of assets and equity stood at -$14.6M; a 1.1x current ratio means near-term coverage and overall balance-sheet strength present different pictures.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 70 / 100
Financial Health Score 70/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Arteris, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
87

Arteris, Inc. held $59.5M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations generated $6.7M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Arteris, Inc. scores 87/100 among other emerging companies.

Dilution
58

Dilution ranks emerging companies on the yearly rate at which their shares outstanding grew across the last three fiscal years (the last two where the earliest reports none), a slower rise ranking higher because each round of funding spreads the same business across more owners. Arteris, Inc. scores 58/100 on it among other emerging companies.

R&D Intensity
75

Arteris, Inc. spent $49.9M on research and development in fiscal year 2025, which was 48.1% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Arteris, Inc. scores 75/100 among other emerging companies.

Revenue Progress
59

Revenue Progress ranks emerging companies on the yearly rate at which their revenue compounded across the last three fiscal years (the last two where the earliest reports none), counted in the currency each company reports in. Arteris, Inc. scores 59/100 on it among other emerging companies.

Burn Trend
95

Burn Trend ranks emerging companies on how far their operating cash flow moved between the newest fiscal year and the one two years earlier, measured against the cash the earlier year used, and a move toward generating cash ranks higher. Arteris, Inc. scores 95/100 on it among other emerging companies.

Balance Sheet
43

Arteris, Inc.'s cash, cash equivalents and investments came to $59.5M at the end of fiscal year 2025, against $129.7M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Arteris, Inc. scores 43/100 among other emerging companies.

Altman Z-Score Grey Zone
2.00

Arteris, Inc. scores 2.00, placing it in the grey zone between 1.81 and 2.99. The largest contribution to the score comes from a market capitalization of $935.5M against total liabilities of $129.7M. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
5/8

Arteris, Inc. passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Mixed
N/A

Arteris, Inc. reported a net loss of $34.7M while generating $6.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Arteris, Inc. reported an operating loss of $33.1M against $193K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$25.8M
YoY+48.1%
QoQ+6.8%
5Y CAGR+23.5%

Arteris, Inc. generated $25.8M in revenue in Q3 2026. This represents an increase of 48.1% from the same quarter a year earlier. Against the prior quarter it is up 6.8%.

EBITDA
-$9.8M
YoYn/m
QoQn/m
5Y CAGRn/m

Arteris, Inc.'s EBITDA was -$9.8M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Net Income
-$11.2M
YoYn/m
QoQn/m
5Y CAGRn/m

Arteris, Inc. reported a net loss of $11.2M in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)
-$0.23
YoYn/m
QoQn/m
5Y CAGRn/m

Arteris, Inc. earned -$0.23 per diluted share (EPS) in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Balance Sheet

Free Cash Flow
-$2.1M
YoY-186.0%
QoQ-124.7%
5Y CAGRn/m

Arteris, Inc. recorded an outflow of $2.1M in free cash flow in Q3 2026, representing a cash shortfall after capex. This represents a decrease of 186.0% from the same quarter a year earlier. Against the prior quarter it is down 124.7%.

Cash & Debt
$71.0M
YoY+307.7%
QoQ-23.9%
5Y CAGR+44.6%

Arteris, Inc. held $71.0M in cash as of Q3 2026; no long-term debt figure is on record for that period.

Shares Outstanding
50M
YoY+13.9%
QoQ+1.2%
5Y CAGR+9.7%

Arteris, Inc. had 50M shares outstanding in Q3 2026. This represents an increase of 13.9% from the same quarter a year earlier. Against the prior quarter it is up 1.2%.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin
86.6%
YoY-3.2pp
QoQ+1.6pp
5Y change-3.5pp

Arteris, Inc.'s gross margin was 86.6% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is down 3.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.6 percentage points.

Operating Margin
-43.9%
YoY+6.2pp
QoQ+13.7pp
5Y change+6.5pp

Arteris, Inc.'s operating margin was -43.9% in Q3 2026, reflecting core business profitability. This is up 6.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 13.7 percentage points.

Net Margin
-43.3%
YoY+8.4pp
QoQ+15.0pp
5Y change+12.2pp

Arteris, Inc.'s net profit margin was -43.3% in Q3 2026, showing the share of revenue converted to profit. This is up 8.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 15.0 percentage points.

Return on Equity
-16.9%
QoQ+3.9pp

Arteris, Inc.'s quarterly ROE was -16.9% in Q3 2026: one quarter's net income over shareholder equity, not annualized. Against the prior quarter it is up 3.9 percentage points.

Capital Allocation

R&D Spending
$16.4M
YoY+29.9%
QoQ-2.0%
5Y CAGR+16.6%

Arteris, Inc. invested $16.4M in research and development in Q3 2026. This represents an increase of 29.9% from the same quarter a year earlier. Against the prior quarter it is down 2.0%.

Capital Expenditures
$375K
YoY-47.6%
QoQ-37.0%
5Y CAGR+23.8%

Arteris, Inc. invested $375K in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 47.6% from the same quarter a year earlier. Against the prior quarter it is down 37.0%.

Share Buybacks

Not reported for Q3 2026.

AIP Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AIP quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$25.8M+48.1%$24.1M+46.2%$22.9M+38.7%$20.1M+30.0%$17.4M+18.3%$16.5M+13.2%$16.5M+27.7%$15.5M+23.9%
Cost of Revenue$3.5M+95.4%$3.6M+107.1%$3.3M+113.0%$1.9M+18.2%$1.8M+20.9%$1.7M+19.5%$1.5M+4.0%$1.6M+8.8%
Gross Profit$22.3M+42.7%$20.5M+39.1%$19.7M+31.2%$18.3M+31.3%$15.6M+18.0%$14.8M+12.5%$15.0M+30.7%$13.9M+25.9%
R&D Expenses$16.4M+29.9%$16.8M+37.7%$14.5M+21.9%$13.2M+14.7%$12.6M+6.1%$12.2M+13.6%$11.9M+9.5%$11.5M+8.1%
SG&A Expenses$17.1M+45.9%$15.5M+42.6%$13.9M+28.5%$13.5M+42.5%$11.7M+26.6%$10.8M+10.1%$10.9M+11.0%$9.5M-1.6%
Operating Income-$11.3Mn/m-$13.9Mn/m-$9.3Mn/m-$8.5Mn/m-$8.7Mn/m-$8.2Mn/m-$7.7Mn/m-$7.1Mn/m
EBITDA-$9.8Mn/m-$12.4Mn/m-$8.0Mn/m-$7.6Mn/m-$7.9Mn/m-$7.4Mn/m-$6.9Mn/m-$6.2Mn/m
Interest Expense$85K+73.5%$30K-28.6%$38K-20.8%$54K+20.0%$49K-10.9%$42K-38.2%$48K-36.8%$45K-40.0%
Income Tax$845K+122.4%$697K-17.6%-$3.7M-1479.9%-$19K-101.5%$380Kn/m$846K-13.2%$268K-27.6%$1.2M+1.9%
Net Income-$11.2Mn/m-$14.1Mn/m-$8.0Mn/m-$8.5Mn/m-$9.0Mn/m-$9.1Mn/m-$8.1Mn/m-$8.2Mn/m
EPS (Basic)-$0.23n/m-$0.30n/m-$0.17n/m-$0.19n/m-$0.21n/m-$0.22n/m-$0.20n/m-$0.20n/m
EPS (Diluted)-$0.23n/m-$0.30n/m-$0.17n/m-$0.19n/m-$0.21n/m-$0.22n/m-$0.20n/m-$0.20n/m
Diluted Shares (Avg)49M+15.5%47M+13.0%46M+11.5%N/A43M+8.8%42M+8.7%41M+8.3%N/A

AIP Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AIP quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$227.9M+111.6%$224.7M+110.2%$139.9M+42.3%$115.0M+8.4%$107.7M+10.3%$106.9M+10.9%$98.3M-3.0%$106.1M+3.2%
Current Assets$134.2M+119.9%$146.3M+137.8%$61.5M+7.2%$82.4M+19.3%$61.0M-2.8%$61.5M+4.5%$57.4M-7.1%$69.1M+18.2%
Cash & Equivalents$71.0M+307.7%$93.3M+479.3%$11.7M-28.7%$33.9M+147.7%$17.4M-2.3%$16.1M-27.2%$16.4M-37.3%$13.7M-0.1%
Short-Term Investments$33.2M+53.8%$28.8M+31.7%$26.4M+1.9%$20.7M-31.4%$21.6M-30.1%$21.9M-7.5%$25.9M+38.8%$30.2M+9.8%
Accounts Receivable$21.0M+27.2%$15.2M-18.8%$14.7M+43.1%$19.2M-6.9%$16.5M+89.1%$18.8M+109.6%$10.3M-16.3%$20.6M+71.7%
Long-Term Investments$16.1M-6.5%$1.2M-92.5%$3.8M-70.4%$4.9M-41.8%$17.2M+195.2%$15.9M+95.8%$12.8M+48.6%$8.5M-27.9%
Goodwill$35.2M+741.5%$35.3M+744.9%$35.2M+742.4%$4.2M0.0%$4.2M0.0%$4.2M0.0%$4.2M0.0%$4.2M0.0%
Total Liabilities$162.1M+36.0%$157.0M+37.3%$137.3M+33.1%$129.7M+20.8%$119.2M+24.8%$114.4M+25.6%$103.1M+12.3%$107.3M+22.4%
Current Liabilities$99.7M+49.4%$93.3M+49.2%$84.5M+49.5%$73.2M+23.5%$66.8M+23.2%$62.6M+20.9%$56.5M+13.5%$59.3M+27.8%
Non-Current Liabilities$62.3M+18.9%$63.7M+22.8%$52.8M+13.2%$56.5M+17.5%$52.4M+26.9%$51.9M+31.7%$46.6M+11.0%$48.0M+16.3%
Total Equity$65.9Mn/m$67.7Mn/m$2.6Mn/m-$14.6Mn/m-$11.4M-618.3%-$7.5M-242.7%-$4.8M-150.5%-$1.2M-107.9%
Retained Earnings-$204.8Mn/m-$193.7Mn/m-$179.6Mn/m-$171.6Mn/m-$163.1Mn/m-$154.1Mn/m-$145.0Mn/m-$136.9Mn/m

Not reported in any period shown, so not listed: Inventory, Long-Term Debt.

AIP Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AIP quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow-$1.8M-154.9%$9.2Mn/m-$7.1M-346.9%$3.2Mn/m$3.2M+183.9%-$2.5M-899.0%$2.9M+499.6%-$2.6Mn/m
Depreciation & Amortization$1.5M+74.6%$1.5M+79.3%$1.3M+59.5%$844K-5.0%$843K-0.1%$845K+6.0%$844K+1.3%$888K+7.1%
Stock-Based Compensation$9.2M+85.4%$6.3M+41.1%$5.5M+27.8%N/A$5.0M+12.9%$4.5M+19.6%$4.3M+17.9%N/A
Capital Expenditures$375K-47.6%$595K+67.6%$295K+61.2%$134K+168.0%$716K+2209.7%$355K+655.3%$183K-6.6%$50K-88.3%
Free Cash Flow-$2.1M-186.0%$8.6Mn/m-$7.4M-374.8%$3.0Mn/m$2.5M+126.4%-$2.8M-1175.8%$2.7M+852.7%-$2.7Mn/m
Investing Cash Flow-$19.8Mn/m-$372K-152.8%-$16.0Mn/m$13.1Mn/m-$1.6Mn/m$705Kn/m-$121K-101.0%-$1.9Mn/m
Financing Cash Flow-$724Kn/m$72.8M+4724.7%$882Kn/m$142K-65.7%-$181Kn/m$1.5M+2641.8%-$52K-218.2%$414Kn/m

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

AIP Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AIP quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Gross Margin86.6%-3.2pp85.0%-4.4pp85.8%-4.9pp90.8%+0.9pp89.9%-0.2pp89.4%-0.6pp90.8%+2.1pp89.8%+1.4pp
Operating Margin-43.9%+6.2pp-57.6%-7.7pp-40.6%+6.1pp-42.0%+3.8pp-50.1%+3.8pp-50.0%+1.1pp-46.6%+23.9pp-45.9%+28.1pp
Net Margin-43.3%+8.4pp-58.3%-2.9pp-34.7%+14.4pp-42.2%+10.7pp-51.6%+0.6pp-55.3%+1.9pp-49.1%+23.5pp-53.0%+31.3pp
Return on Equity-16.9%-20.8%-307.2%N/AN/AN/AN/AN/A
Return on Assets-4.9%+3.5pp-6.3%+2.3pp-5.7%+2.6pp-7.4%+0.3pp-8.3%-0.5pp-8.5%+0.1pp-8.3%+1.0pp-7.7%+2.5pp
Current Ratio1.35+0.4x1.57+0.6x0.73-0.3x1.130.0x0.91-0.2x0.98-0.2x1.02-0.2x1.17-0.1x
Liabilities-to-Equity2.462.3252.99N/AN/AN/AN/AN/A
Asset Turnover0.110.0x0.110.0x0.160.0x0.180.0x0.160.0x0.150.0x0.170.0x0.150.0x
FCF Margin-8.3%-22.4pp35.7%+52.9pp-32.1%-48.3pp15.1%+32.4pp14.2%+6.8pp-17.2%-19.0pp16.2%+14.0pp-17.3%+9.9pp

Not reported in any period shown, so not listed: Debt-to-Equity.

Note: Shareholder equity is negative (-$14.6M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Arteris, Inc. AIP FY2025 $70.6M -$34.7M -49.2% $935.5M 70/100
POET Technologies Inc. POET FY2025 $1.1M -$63.0M N/A $740.4M 54/100
Ambiq Micro, Inc. AMBQ FY2025 $72.5M -$36.5M -50.3% $1.1B 53/100
Alpha and Omega Semiconductor Limited AOSL FY2026 $678.9M -$42.3M -6.2% $771.8M 45/100
CEVA Inc. CEVA FY2025 $109.6M -$10.6M -9.7% $718.6M 67/100
Wolfspeed, Inc. WOLF FY2026 N/A $4.4M N/A $1.2B —

Frequently Asked Questions

Arteris, Inc. (AIP) reported $70.6M in total revenue for fiscal year 2025. This represents a 22.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Arteris, Inc. (AIP) revenue grew by 22.3% year-over-year, from $57.7M to $70.6M in fiscal year 2025.

No, Arteris, Inc. (AIP) reported a net loss of $41.7M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net loss of $34.7M, with a net profit margin of -49.2%.

Arteris, Inc. (AIP) reported diluted earnings per share of -$0.82 for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Arteris, Inc. (AIP) had EBITDA of -$29.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Arteris, Inc. (AIP) had a gross margin of 90.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Arteris, Inc. (AIP) had an operating margin of -46.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Arteris, Inc. (AIP) had a net profit margin of -49.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Arteris, Inc. (AIP) generated $5.3M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Arteris, Inc. (AIP) generated $6.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Arteris, Inc. (AIP) had $115.0M in total assets as of fiscal year 2025, including both current and long-term assets.

Arteris, Inc. (AIP) invested $1.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Arteris, Inc. (AIP) invested $49.9M in research and development during fiscal year 2025.

Arteris, Inc. (AIP) had 45M shares outstanding as of fiscal year 2025.

Arteris, Inc. (AIP) had a current ratio of 1.13 as of fiscal year 2025, which is considered adequate.

Arteris, Inc. (AIP) had a return on assets of -30.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Arteris, Inc. (AIP) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to September 30, 2026). The market capitalization is $935.5M as of Nov 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Arteris, Inc. (AIP) trades at 10.1x sales, its market capitalization divided by $93.0M revenue, trailing 12 months to September 30, 2026. The market capitalization is $935.5M as of Nov 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Arteris, Inc. (AIP) has negative shareholder equity of -$14.6M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Arteris, Inc. (AIP) has an Altman Z-Score of 2.00, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Arteris, Inc. (AIP) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Arteris, Inc. (AIP) reported a net loss of $34.7M while generating $6.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Arteris, Inc. (AIP) reported an operating loss of $33.1M against $193K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Arteris, Inc. (AIP) scores 70 out of 100 on our Financial Health Score, indicating strong standing within its emerging companies peer group. The score is the average of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top